| Rank | Title | Journal | Year | PubWeight™‹?› |
|---|---|---|---|---|
| 1 | Tat HIV-1 primary and tertiary structures critical to immune response against non-homologous variants. | J Biol Chem | 2002 | 1.00 |
| 2 | Full-length HIV-1 Tat protein necessary for a vaccine. | Vaccine | 2004 | 0.87 |
| 3 | A possible improvement for structure-based drug design illustrated by the discovery of a Tat HIV-1 inhibitor. | Bioorg Med Chem Lett | 2004 | 0.75 |